| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0093 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |